SWOG S2107

Primary Category:

Treatment Protocols

Disease Category:

Colon, Colon Metastatic, Rectal, Rectal Metastatic

Status:

New, Open

Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer

NCT#05308446